Reduced GM1 ganglioside in CFTR-deficient human airway cells results in decreased β1-integrin signaling and delayed wound repair

American Journal of Physiology - Cell Physiology

Volumn 306, Issue 9, 2014, Pages

  Itokazu, Yutaka ^a,b,c   Pagano, Richard E ^a   Schroeder, Andreas S ^a   O'Grady, Scott M ^d   Limper, Andrew H ^a   Marks, David L ^a  

^a MAYO CLINIC   (United States)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Cell attachment; Chloride channels; Pulmonary epithelial cells; Sialo lipids

Indexed keywords

BETA1 INTEGRIN; CRK ASSOCIATED SUBSTRATE PROTEIN; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; FOCAL ADHESION KINASE; GANGLIOSIDE GM1; GANGLIOSIDE GM3; GLYCOSPHINGOLIPID; LIPID; SHORT HAIRPIN RNA; TYROSINE;

ARTICLE; CELL MIGRATION; CONTROLLED STUDY; EPITHELIUM CELL; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOBLOTTING; LIPID ANALYSIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; WOUND HEALING IMPAIRMENT;

CELL ATTACHMENT; CHLORIDE CHANNELS; PULMONARY EPITHELIAL CELLS; SIALO-LIPIDS;

ANTIGENS, CD29; CELL LINE; CELL MOVEMENT; CRK-ASSOCIATED SUBSTRATE PROTEIN; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; DOWN-REGULATION; ELECTRIC IMPEDANCE; EPITHELIAL CELLS; FOCAL ADHESION KINASE 1; G(M1) GANGLIOSIDE; HUMANS; LUNG; PHOSPHORYLATION; RNA INTERFERENCE; TIME FACTORS; TRANSFECTION; TYROSINE; WOUND HEALING;

EID: 84900563188     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00168.2013     Document Type: Article

References (70)

1. Barasch J, Kiss B, Prince A, Saiman L, Gruenert D, al-Awqati Q. Defective acidification of intracellular organelles in cystic fibrosis. Nature 352: 70-73, 1991.
2. Becker KA, Riethmuller J, Luth A, Doring G, Kleuser B, Gulbins E. Acid sphingomyelinase inhibitors normalize pulmonary ceramide and inflammation in cystic fibrosis. Am J Respir Cell Mol Biol 42: 716-724, 2010.
3. Becker KA, Riethmuller J, Zhang Y, Gulbins E. The role of sphingolipids and ceramide in pulmonary inflammation in cystic fibrosis. Open Respir Med J 4: 39-47, 2010.
4. Becker KA, Tummler B, Gulbins E, Grassme H. Accumulation of ceramide in the trachea and intestine of cystic fibrosis mice causes inflammation and cell death. Biochem Biophys Res Commun 403: 368-374, 2010.
5. Belcher CN, Vij N. Protein processing and inflammatory signaling in cystic fibrosis: challenges and therapeutic strategies. Curr Mol Med 10: 82-94, 2010.
6. Bhaumik SK, Singh MK, Karmakar S, De T. Immuno stimulating glycophosphosphingolipid antigen from Leishmania donovani is recognized by visceral leishmaniasis patient sera. Mol Biochem Parasitol 159: 121-129, 2008.
7. Bielawski J, Szulc ZM, Hannun YA, Bielawska A. Simultaneous quantitative analysis of bioactive sphingolipids by high-performance liquid chromatography-tandem mass spectrometry. Methods 39: 82-91, 2006.
8. Brodlie M, McKean MC, Johnson GE, Gray J, Fisher AJ, Corris PA, Lordan JL, Ward C. Ceramide is increased in the lower airway epithelium of people with advanced cystic fibrosis lung disease. Am J Respir Crit Care Med 182: 369-375, 2010.
9. Chen CS, Bach G, Pagano RE. Abnormal transport along the lysosomal pathway in mucolipidosis, type IV disease. Proc Natl Acad Sci USA 95: 6373-6378, 1998.
10. Cheng ZJ, Singh RD, Marks DL, Pagano RE. Membrane microdomains, caveolae, and caveolar endocytosis of sphingolipids. Mol Membr Biol 23: 101-110, 2006.
11. Di A, Brown ME, Deriy LV, Li C, Szeto FL, Chen Y, Huang P, Tong J, Naren AP, Bindokas V, Palfrey HC, Nelson DJ. CFTR regulates phagosome acidification in macrophages and alters bactericidal activity. Nat Cell Biol 8: 933-944, 2006.
12. 1-integrin signaling and delayed wound repair. " Am J Physiol Cell Physiol (March 13, 2014). doi:10.1152/ajpcell. 00075.2014.
13. Dosanjh A, Lencer W, Brown D, Ausiello DA, Stow JL. Heterologous expression of ΔF508 CFTR results in decreased sialylation of membrane glycoconjugates. Am J Physiol Cell Physiol 266: C360-C366, 1994.
14. Dosanjh A, Muchmore EA. Expression of DeltaF508 cystic fibrosis transmembrane regulator (CFTR) decreases membrane sialylation. Open Respir Med J 3: 79-84, 2009.
15. Dunn KW, Park J, Semrad CE, Gelman DL, Shevell T, McGraw TE. Regulation of endocytic trafficking and acidification are independent of the cystic fibrosis transmembrane regulator. J Biol Chem 269: 5336-5345, 1994.
16. Glick MC, Kothari VA, Liu A, Stoykova LI, Scanlin TF. Activity of fucosyltransferases and altered glycosylation in cystic fibrosis airway epithelial cells. Biochimie 83: 743-747, 2001.
17. Granio O, Norez C, Ashbourne Excoffon KJ, Karp PH, Lusky M, Becq F, Boulanger P, Zabner J, Hong SS. Cellular localization and activity of Ad-delivered GFP-CFTR in airway epithelial and tracheal cells. Am J Respir Cell Mol Biol 37: 631-639, 2007.
18. Guilbault C, De Sanctis JB, Wojewodka G, Saeed Z, Lachance C, Skinner TA, Vilela RM, Kubow S, Lands LC, Hajduch M, Matouk E, Radzioch D. Fenretinide corrects newly found ceramide deficiency in cystic fibrosis. Am J Respir Cell Mol Biol 38: 47-56, 2008.
19. Guilbault C, Wojewodka G, Saeed Z, Hajduch M, Matouk E, De Sanctis JB, Radzioch D. Cystic fibrosis fatty acid imbalance is linked to ceramide deficiency and corrected by fenretinide. Am J Respir Cell Mol Biol 41: 100-106, 2009.
20. Haggie PM, Verkman AS. Defective organellar acidification as a cause of cystic fibrosis lung disease: reexamination of a recurring hypothesis. Am J Physiol Lung Cell Mol Physiol 296: L859-L867, 2009.
21. Hajj R, Lesimple P, Nawrocki-Raby B, Birembaut P, Puchelle E, Coraux C. Human airway surface epithelial regeneration is delayed and abnormal in cystic fibrosis. J Pathol 211: 340-350, 2007.
22. Hamai H, Keyserman F, Quittell LM, Worgall TS. Defective CFTR increases synthesis and mass of sphingolipids that modulate membrane composition and lipid signaling. J Lipid Res 50: 1101-1108, 2009.
23. Hamamura K, Tsuji M, Ohkawa Y, Nakashima H, Miyazaki S, Urano T, Yamamoto N, Ueda M, Furukawa K. Focal adhesion kinase as well as p130Cas and paxillin is crucially involved in the enhanced malignant properties under expression of ganglioside GD3 in melanoma cells. Biochim Biophys Acta 1780: 513-519, 2008.
24. Cas, a substrate associated with v-Src and v-Crk, localizes to focal adhesions and binds to focal adhesion kinase. J Biol Chem 271: 13649-13655, 1996.
25. Hashiramoto A, Mizukami H, Yamashita T. Ganglioside GM3 promotes cell migration by regulating MAPK and c-Fos/AP-1. Oncogene 25: 3948-3955, 2006.
26. Hollande E, Salvador-Cartier C, Alvarez L, Fanjul M. Expression of a wild-type CFTR maintains the integrity of the biosynthetic/secretory pathway in human cystic fibrosis pancreatic duct cells. J Histochem Cytochem 53: 1539-1552, 2005.
27. Jacquot J, Tabary O, Clement A. Hyperinflammation in airways of cystic fibrosis patients: what's new? Expert Rev Mol Diagn 8: 359-363, 2008.
28. Kirk KL. CFTR channels and wound healing. Focus on "Cystic fibrosis transmembrane conductance regulator is involved in airway epithelial wound repair. " Am J Physiol Cell Physiol 299: C888-C890, 2010.
29. Ledeen RW, Yu RK. Gangliosides: structure, isolation, and analysis. Methods Enzymol 83: 139-191, 1982.
30. Liu Y, Yan S, Wondimu A, Bob D, Weiss M, Sliwinski K, Villar J, Notario V, Sutherland M, Colberg-Poley AM, Ladisch S. Ganglioside synthase knockout in oncogene-transformed fibroblasts depletes gangliosides and impairs tumor growth. Oncogene 29: 3297-3306, 2010.
31. Luzio JP, Rous BA, Bright NA, Pryor PR, Mullock BM, Piper RC. Lysosome-endosome fusion and lysosome biogenesis. J Cell Sci 113: 1515-1524, 2000.
32. Maccioni HJ, Quiroga R, Ferrari ML. Cellular and molecular biology of glycosphingolipid glycosylation. J Neurochem 117: 589-602, 2011.
33. Maille E, Trinh NT, Prive A, Bilodeau C, Bissonnette E, Grandvaux N, Brochiero E. Regulation of normal and cystic fibrosis airway epithelial repair processes by TNF-after injury. Am J Physiol Lung Cell Mol Physiol 301: L945-L955, 2011.
34. Marks DL, Paul P, Kamisaka Y, Pagano RE. Methods for studying glucosylceramide synthase. Methods Enzymol 311: 50-59, 1999.
35. Martin OC, Pagano RE. Internalization and sorting of a fluorescent analog of glucosylceramide to the Golgi apparatus of human skin fibroblasts: utilization of endocytic and nonendocytic transport mechanisms. J Cell Biol 125: 769-781, 1994.
36. Miura Y, Kainuma M, Jiang H, Velasco H, Vogt PK, Hakomori S. Reversion of the Jun-induced oncogenic phenotype by enhanced synthesis of sialosyllactosylceramide (GM3 ganglioside). Proc Natl Acad Sci USA 101: 16204-16209, 2004.
37. Mogayzel PJ Jr, Flume PA. Update in cystic fibrosis 2009. Am J Respir Crit Care Med 181: 539-544, 2010.
38. Noe J, Petrusca D, Rush N, Deng P, VanDemark M, Berdyshev E, Gu Y, Smith P, Schweitzer K, Pilewsky J, Natarajan V, Xu Z, Obukhov AG, Petrache I. CFTR regulation of intracellular pH and ceramides is required for lung endothelial cell apoptosis. Am J Respir Cell Mol Biol 41: 314-323, 2009.
39. Ohkawa Y, Miyazaki S, Hamamura K, Kambe M, Miyata M, Tajima O, Ohmi Y, Yamauchi Y, Furukawa K. Ganglioside GD3 enhances adhesion signals and augments malignant properties of melanoma cells by recruiting integrins to glycolipid-enriched microdomains. J Biol Chem 285: 27213-27223, 2010.
40. Ono M, Handa K, Sonnino S, Withers DA, Nagai H, Hakomori S. GM3 ganglioside inhibits CD9-facilitated haptotactic cell motility: coexpression of GM3 and CD9 is essential in the downregulation of tumor cell motility and malignancy. Biochemistry 40: 6414-6421, 2001.
41. Puri V, Jefferson JR, Singh RD, Wheatley CL, Marks DL, Pagano RE. Sphingolipid storage induces accumulation of intracellular cholesterol by stimulating SREBP-1 cleavage. J Biol Chem 278: 20961-20970, 2003.
42. Regina Todeschini A, Hakomori SI. Functional role of glycosphingolipids and gangliosides in control of cell adhesion, motility, and growth, through glycosynaptic microdomains. Biochim Biophys Acta 1780: 421-433, 2008.
43. Rhim AD, Stoykova LI, Trindade AJ, Glick MC, Scanlin TF. Altered terminal glycosylation and the pathophysiology of CF lung disease. J Cyst Fibros 3, Suppl 2: 95-96, 2004.
44. Rottner M, Freyssinet JM, Martinez MC. Mechanisms of the noxious inflammatory cycle in cystic fibrosis. Respir Res 10: 23, 2009.
45. Saiman L, Prince A. Pseudomonas aeruginosa pili bind to asialoGM1 which is increased on the surface of cystic fibrosis epithelial cells. J Clin Invest 92: 1875-1880, 1993.
46. Sandhoff K, Harzer K. Gangliosides and gangliosidoses: principles of molecular and metabolic pathogenesis. J Neurosci 33: 10195-10208, 2013.
47. Schiller KR, Maniak PJ, O'Grady SM. Cystic fibrosis transmembrane conductance regulator is involved in airway epithelial wound repair. Am J Physiol Cell Physiol 299: C912-C921, 2010.
48. Shibuya H, Hamamura K, Hotta H, Matsumoto Y, Nishida Y, Hattori H, Furukawa K, Ueda M. Enhancement of malignant properties of human osteosarcoma cells with disialyl gangliosides GD2/GD3. Cancer Sci 103: 1656-1664, 2012.
49. Shute J, Marshall L, Bodey K, Bush A. Growth factors in cystic fibrosis-when more is not enough. Paediatr Respir Rev 4: 120-127, 2003.
50. Simons K, Gerl MJ. Revitalizing membrane rafts: new tools and insights. Nat Rev Mol Cell Biol 11: 688-699, 2010.
51. Singh RD, Holicky EL, Cheng Z, Kim SY, Wheatley CL, Marks DL, Bittman R, Pagano RE. Inhibition of caveolar uptake, SV40 infection, and β1-integrin signaling by a nonnatural glycosphingolipid stereoisomer. J Cell Biol 176: 895-901, 2007.
52. Singh RD, Marks DL, Holicky EL, Wheatley CL, Kaptzan T, Sato SB, Kobayashi T, Ling K, Pagano RE. Gangliosides and β1-integrin are required for caveolae and membrane domains. Traffic 11: 348-360, 2010.
53. Slomiany A, Murty VL, Aono M, Snyder CE, Herp A, Slomiany BL. Lipid composition of tracheobronchial secretions from normal individuals and patients with cystic fibrosis. Biochim Biophys Acta 710: 106-111, 1982.
54. Stoykova LI, Liu A, Scanlin TF, Glick MC. 1,3Fucosyltransferases in cystic fibrosis airway epithelial cells. Biochimie 85: 363-367, 2003.
55. Sun YH, Reid B, Fontaine JH, Miller LA, Hyde DM, Mogilner A, Zhao M. Airway epithelial wounds in rhesus monkey generate ionic currents that guide cell migration to promote healing. J Appl Physiol 111: 1031-1041, 2011.
56. Sung CC, O'Toole EA, Lannutti BJ, Hunt J, O'Gorman M, Woodley DT, Paller AS. Integrin α5β1 expression is required for inhibition of keratinocyte migration by ganglioside GT1b. Exp Cell Res 239: 311-319, 1998.
57. Tang BL, Gee HY, Lee MG. The cystic fibrosis transmembrane conductance regulator's expanding SNARE interactome. Traffic 12: 364-371, 2011.
58. Teichgraber V, Ulrich M, Endlich N, Riethmuller J, Wilker B, De Oliveira-Munding CC, van Heeckeren AM, Barr ML, von Kurthy G, Schmid KW, Weller M, Tummler B, Lang F, Grassme H, Doring G, Gulbins E. Ceramide accumulation mediates inflammation, cell death and infection susceptibility in cystic fibrosis. Nat Med 14: 382-391, 2008.
59. Toledo MS, Suzuki E, Handa K, Hakomori S. Effect of ganglioside and tetraspanins in microdomains on interaction of integrins with fibroblast growth factor receptor. J Biol Chem 280: 16227-16234, 2005.
60. Trinh NT, Bardou O, Prive A, Maille E, Adam D, Lingee S, Ferraro P, Desrosiers MY, Coraux C, Brochiero E. Improvement of defective cystic fibrosis airway epithelial wound repair after CFTR rescue. Eur Respir J 40: 1390-1400, 2012.
61. Ulrich M, Worlitzsch D, Viglio S, Siegmann N, Iadarola P, Shute JK, Geiser M, Pier GB, Friedel G, Barr ML, Schuster A, Meyer KC, Ratjen F, Bjarnsholt T, Gulbins E, Doring G. Alveolar inflammation in cystic fibrosis. J Cyst Fibros 9: 217-227, 2010.
62. Valentino LA, Ladisch S. Tumor gangliosides enhance α2β1 integrindependent platelet activation. Biochim Biophys Acta 1316: 19-28, 1996.
63. Van Slambrouck S, Hilkens J, Bisoffi M, Steelant WF. AsialoGM1 and integrin α2β1 mediate prostate cancer progression. Int J Oncol 35: 693-699, 2009.
64. Wang XQ, Sun P, Paller AS. Ganglioside GM3 inhibits matrix metalloproteinase-9 activation and disrupts its association with integrin. J Biol Chem 278: 25591-25599, 2003.
65. Wang XQ, Sun P, Paller AS. Gangliosides inhibit urokinase-type plasminogen activator (uPA)-dependent squamous carcinoma cell migration by preventing uPA receptor/αβ integrin/epidermal growth factor receptor interactions. J Invest Dermatol 124: 839-848, 2005.
66. Weisz OA. Acidification and protein traffic. Int Rev Cytol 226: 259-319, 2003.
67. Weixel KM, Bradbury NA. Endocytic adaptor complexes bind the C-terminal domain of CFTR. Pflügers Arch 443, Suppl 1: S70-S74, 2001.
68. Wozniak MA, Modzelewska K, Kwong L, Keely PJ. Focal adhesion regulation of cell behavior. Biochim Biophys Acta 1692: 103-119, 2004.
69. Xu Y, Krause A, Hamai H, Harvey BG, Worgall TS, Worgall S. Proinflammatory phenotype and increased caveolin-1 in alveolar macrophages with silenced CFTR mRNA. PLos One 5: e11004, 2010.
70. Zhang Y, Li X, Grassme H, Doring G, Gulbins E. Alterations in ceramide concentration and pH determine the release of reactive oxygen species by Cftr-deficient macrophages on infection. J Immunol 184: 5104-5111, 2010.